PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2
S. Mazumder, R. Rastogi, A. Undale, K. Arora, N. M. Arora, B. P. Das Purkayastha, D. Kumar, A. Joseph, B. Mali, V. B. Arya, S. Kalyanaraman, A. Mukherjee, A. Gupta, S. Potdar, S. S. Roy, , P. K. Kundu
This paper develops a triple antigen VLP vaccine candidate, PRAK-03202, against SARS-CoV-2 and shows it induces neutralizing antibodies and Th1 immune responses in mice.
bioRxiv · Oct 30, 2020Immunology